Published in Neuroscience on February 01, 1984
Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest (2002) 1.60
Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A (1991) 1.49
Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J Physiol (1987) 1.27
The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol (1988) 1.25
Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A (1987) 1.22
Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond B Biol Sci (2006) 1.20
Minireview: The value of looking backward: the essential role of the hindbrain in counterregulatory responses to glucose deficit. Endocrinology (2011) 1.06
Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol (2010) 1.05
Calcium and sodium currents evoked by action potential waveforms in rat sympathetic neurones. J Physiol (1995) 0.99
Simultaneous silencing of Npy and Dbh expression in hindbrain A1/C1 catecholamine cells suppresses glucoprivic feeding. J Neurosci (2009) 0.96
Neuroendocrine regulation of appetitive ingestive behavior. Front Neurosci (2013) 0.94
Participation of hindbrain AMP-activated protein kinase in glucoprivic feeding. Diabetes (2011) 0.92
Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci U S A (1985) 0.89
Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc Natl Acad Sci U S A (1987) 0.88
The cardiovascular actions of clonidine and neuropeptide-Y in the ventrolateral medulla of the rat. Br J Pharmacol (1989) 0.88
Hyperphagia and obesity produced by arcuate injection of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic peptide genes. Peptides (2008) 0.86
Beyond Leptin: Emerging Candidates for the Integration of Metabolic and Reproductive Function during Negative Energy Balance. Front Endocrinol (Lausanne) (2011) 0.84
Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway. Hum Mol Genet (2014) 0.82
Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y. Br J Pharmacol (2011) 0.81
Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development. Cell Mol Neurobiol (2004) 0.81
Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology (1986) 0.80
Surgical cure of hypertension in a patient with brainstem capillary haemangioblastoma containing neuropeptide Y. Postgrad Med J (1995) 0.80
Activation of NPY receptors suppresses excitatory synaptic transmission in a taste-feeding network in the lower brain stem. Am J Physiol Regul Integr Comp Physiol (2012) 0.77
Orexin-A enhances feeding in male rats by activating hindbrain catecholamine neurons. Am J Physiol Regul Integr Comp Physiol (2015) 0.77
Neuropeptide Y-like substances are released from the rostral brainstem of cats during the muscle pressor response. J Physiol (1996) 0.77
Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats. Psychopharmacology (Berl) (2014) 0.77
Neuropeptide Y input to the rat basolateral amygdala complex and modulation by conditioned fear. J Comp Neurol (2016) 0.76
Hindbrain catecholamine neurons control rapid switching of metabolic substrate use during glucoprivation in male rats. Endocrinology (2013) 0.76
Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide. Br J Clin Pharmacol (1990) 0.76
Ultrastructural Correlates of Enhanced Norepinephrine and Neuropeptide Y Cotransmission in the Spontaneously Hypertensive Rat Brain. ASN Neuro (2015) 0.75
Neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON) in the developing and adult spinal cord of a reptile. J Anat (1990) 0.75
Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci (1992) 0.75
Rapid decrease in neuropeptide Y gene expression in rat adrenal gland induced by the alpha 2-adrenoceptor agonist, clonidine. Br J Pharmacol (1991) 0.75
Opioid modulation of the response of preoptic neurones to stimulation of the ventral noradrenergic tract in female rats. J Physiol (1988) 0.75
Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model. Indian J Endocrinol Metab (2012) 0.75
Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides. J Med Chem (1999) 9.39
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (1983) 8.18
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science (2001) 4.25
Polypeptide with broad biological activity: isolation from small intestine. Science (1970) 4.14
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A (1998) 4.14
Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 4.06
Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol (1996) 3.65
Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology (1999) 3.60
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54
Second brain death examination may negatively affect organ donation. Neurology (2010) 3.48
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A (2000) 3.44
Peptidergic neurones. Nature (1980) 3.36
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. Acta Physiol Scand (1977) 3.15
Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett (1983) 3.12
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A (2000) 3.04
Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. J Neurosci (2001) 2.96
Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93
The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A (1998) 2.91
Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A (1982) 2.89
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature (1999) 2.89
Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci (1999) 2.81
Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem (1968) 2.72
Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res (1975) 2.72
Involvement of the central nucleus of the amygdala and nucleus accumbens core in mediating Pavlovian influences on instrumental behaviour. Eur J Neurosci (2001) 2.71
Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature (1997) 2.66
Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci (2000) 2.64
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol (1969) 2.61
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A (1989) 2.59
Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem (1972) 2.59
Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat. Neuroscience (1976) 2.56
Structure of porcine secretin. The amino acid sequence. Eur J Biochem (1970) 2.44
Drug addiction and the memory systems of the brain. Ann N Y Acad Sci (2008) 2.36
Substance p: localization in the central nervous system and in some primary sensory neurons. Science (1975) 2.33
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 2.33
Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab (1996) 2.33
Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature (1980) 2.31
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
The no-scalpel vasectomy. J Urol (1991) 2.24
Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand (1982) 2.23
Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav (2001) 2.20
Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci (2000) 2.19
Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience (1989) 2.19
Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci (2000) 2.18
The effects of d-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology (Berl) (2000) 2.16
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry (1992) 2.15
Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A (1987) 2.13
A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem (1999) 2.12
Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology (2000) 2.12
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med (1998) 2.11
Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11
Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc Natl Acad Sci U S A (1977) 2.11
Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res (1983) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (1987) 2.09
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function. Behav Brain Res (2002) 2.06
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res (1984) 2.05
N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett (1980) 2.04
Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci U S A (1982) 2.03
Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol (Copenh) (1973) 2.03
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics (2001) 2.00
A multisite field test of the acceptability of physical activity counseling in primary care: project PACE. Am J Prev Med (1996) 2.00
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals. Neuroscience (1978) 1.99
Drug addiction: bad habits add up. Nature (1999) 1.97
Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology (2001) 1.97
Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol (1985) 1.97
Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem (1991) 1.95
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Clinical and diagnostic features of tuberculous arthritis. Am J Med (1972) 1.93
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol (1982) 1.91
Complementary roles for the amygdala and hippocampus in aversive conditioning to explicit and contextual cues. Neuroscience (1991) 1.90
High nitric oxide production in human paranasal sinuses. Nat Med (1995) 1.90